TrellOss Porous Ti Interbody System
Spinal Fusion
ApprovedActive
Key Facts
About HighRidge Medical
HighRidge Medical is a private, commercial-stage medical device company specializing in spinal implants and enabling technologies. Its portfolio targets key segments of spine surgery, including cervical disc replacement (Mobi-C®, ROI-C®), deformity correction (Vital™, The Tether®), and interbody fusion (TrellOss®, FlareHawk®). The company leverages a strong IP portfolio and a commitment to surgeon education to drive adoption. Its business model is centered on direct sales of its approved devices, supported by grants and training programs for healthcare professionals.
View full company profileTherapeutic Areas
Other Spinal Fusion Drugs
| Drug | Company | Phase |
|---|---|---|
| JAZBI™ Cubes | SDIP Innovations | Preclinical |
| Expandable Interbody Portfolio | Globus Medical | Iterative Development |
| Mimetic Metal Technology Development | CoreLink Surgical | Development/Commercial |
| Bone Graft Substitute | BiologicsMD | Pre-clinical |
| VisuALIF | SpineSmith | Commercial |
| ASTRO Registry | Artoss | Post-Market |
| Hive Smart Implant Exploration | NanoHive Medical | Pre-clinical R&D |
| ProLift Pivot Expandable Spacer System | Life Spine | FDA Cleared |
| NEXXT MATRIXX Clinical Evidence Study | Nexxt Spine | Post-Market Study |
| AGA111 | Angitia Biopharmaceuticals | Phase 3 |
| X-PAC® Portfolio Expansion | Expanding Innovations | Development |
| SOLACE™ | Xenix Medical | Commercial |